Home Fluorides 209960-29-2
209960-29-2,MFCD09029885
Catalog No.:AA00BS6A

209960-29-2 | 2-Fluoro-4-(morpholin-4-yl)aniline

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$254.00   $178.00
- +
1g
95%
in stock  
$344.00   $241.00
- +
5g
95%
in stock  
$1,208.00   $846.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00BS6A
Chemical Name:
2-Fluoro-4-(morpholin-4-yl)aniline
CAS Number:
209960-29-2
Molecular Formula:
C10H13FN2O
Molecular Weight:
196.2214
MDL Number:
MFCD09029885
SMILES:
Nc1ccc(cc1F)N1CCOCC1
Properties
Computed Properties
 
Complexity:
185  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
1.2  

Downstream Synthesis Route

[1]Quan,MimiL.;Lam,PatrickY.S.;Han,Qi;Pinto,DonaldJ.P.;He,MingY.;Li,Renhua;Ellis,ChristopherD.;Clark,CharlesG.;Teleha,ChristopherA.;Sun,Jung-Hui;Alexander,RichardS.;Bai,Steve;Luettgen,JosephM.;Knabb,RobertM.;Wong,PancrasC.;Wexler,RuthR.[JournalofMedicinalChemistry,2005,vol.48,#6,p.1729-1744]

[1]Fellowes,Thomas;Hong,Yuning;Lobachevsky,Pavel;Martin,RogerF.;Owyong,TzeCin;Skene,ColinE.;White,JonathanM.[Arkivoc,2022,vol.2022,#4]

[2]Cantillo,David;Moghaddam,MojtabaMirhosseini;Kappe,C.Oliver[JournalofOrganicChemistry,2013,vol.78,#9,p.4530-4542]

[3]Örkényi,Róbert;Éles,János;Faigl,Ferenc;Vincze,Péter;Prechl,Anita;Szakács,Zoltán;Kóti,János;Greiner,István[AngewandteChemie-InternationalEdition,2017,vol.56,#30,p.8742-8745][Angew.Chem.,2017,vol.129,#30,p.8868-8871,4]

[4]Quan,MimiL.;Lam,PatrickY.S.;Han,Qi;Pinto,DonaldJ.P.;He,MingY.;Li,Renhua;Ellis,ChristopherD.;Clark,CharlesG.;Teleha,ChristopherA.;Sun,Jung-Hui;Alexander,RichardS.;Bai,Steve;Luettgen,JosephM.;Knabb,RobertM.;Wong,PancrasC.;Wexler,RuthR.[JournalofMedicinalChemistry,2005,vol.48,#6,p.1729-1744]

[5]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-EP946508,2009,B1Locationinpatent:Page/Pagecolumn92

[6]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US6339099,2002,B1Locationinpatent:Pagecolumn105-106

[7]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-EP991638,2005,B1Locationinpatent:Page/Pagecolumn46

[8]Locationinpatent:schemeortablePatil,SudhakarG.;Bagul,RahulR.;Swami,MangeshS.;Kotharkar,Nandini;Darade,Kalpana[ChineseChemicalLetters,2011,vol.22,#8,p.883-886]

[9]CurrentPatentAssignee:SINOBIOPHARMACEUTICALLIMITED-EP3640247,2020,A1Locationinpatent:Paragraph0293;0295

209960-29-2   
1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-5-(2-fluoro-4-morpholinophenyl)aminocarbonylpyrazole 

[1]Quan,MimiL.;Lam,PatrickY.S.;Han,Qi;Pinto,DonaldJ.P.;He,MingY.;Li,Renhua;Ellis,ChristopherD.;Clark,CharlesG.;Teleha,ChristopherA.;Sun,Jung-Hui;Alexander,RichardS.;Bai,Steve;Luettgen,JosephM.;Knabb,RobertM.;Wong,PancrasC.;Wexler,RuthR.[JournalofMedicinalChemistry,2005,vol.48,#6,p.1729-1744]

[1]Quan,MimiL.;Lam,PatrickY.S.;Han,Qi;Pinto,DonaldJ.P.;He,MingY.;Li,Renhua;Ellis,ChristopherD.;Clark,CharlesG.;Teleha,ChristopherA.;Sun,Jung-Hui;Alexander,RichardS.;Bai,Steve;Luettgen,JosephM.;Knabb,RobertM.;Wong,PancrasC.;Wexler,RuthR.[JournalofMedicinalChemistry,2005,vol.48,#6,p.1729-1744]

[2]Patil,SudhakarG.;Bagul,RahulR.;Swami,MangeshS.;Kotharkar,Nandini;Darade,Kalpana[ChineseChemicalLetters,2011,vol.22,#8,p.883-886]

[3]Örkényi,Róbert;Éles,János;Faigl,Ferenc;Vincze,Péter;Prechl,Anita;Szakács,Zoltán;Kóti,János;Greiner,István[AngewandteChemie-InternationalEdition,2017,vol.56,#30,p.8742-8745][Angew.Chem.,2017,vol.129,#30,p.8868-8871,4]

[4]CurrentPatentAssignee:SINOBIOPHARMACEUTICALLIMITED-EP3640247,2020,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:209960-29-2 Molecular Formula|209960-29-2 MDL|209960-29-2 SMILES|209960-29-2 2-Fluoro-4-(morpholin-4-yl)aniline